Login / Signup

Clinical analysis of uterine intravenous leiomyomatosis: A retrospective study of 260 cases.

Jing PengFangfang ZhongYuemeng ZhuMingxing ZhangMeng ZhangChong LuYumeng WangXingling QiCongwen WangGuiling Li
Published in: The journal of obstetrics and gynaecology research (2021)
The use of gonadotrophin releasing hormone agonist (GnRHa) cannot reduce the postsurgical recurrence rate of patients with UIVL. Compared to total hysterectomy and bilateral salpingo-oophorectomy (TH-BSO), total hysterectomy (TH) does not increase the odds of recurrence, but the chance of recurrence with tumorectomy (TE) is 20 times higher than that of TH-BSO.
Keyphrases
  • free survival
  • high dose
  • low dose
  • breast cancer risk